Oculoplasty in India and UAE | Complete Patient Guide

• EYELID DISORDERS — Ideal candidates include patients with: ptosis (drooping upper eyelid) causing visual field loss >30° on Goldmann perimetry or levator function <4mm; symptomatic dermatochalasis (excess upper eyelid skin) obstructing the superior visual field; cicatricial or involutional entropion/ectropion causing corneal irritation, recurrent conjunctivitis, or epiphora; trichiasis (misdirected lashes) unresponsive to epilation; eyelid retraction secondary to thyroid eye disease (Clinical Activity Score ≥3).

• LACRIMAL SYSTEM DISORDERS — Candidates include patients with confirmed primary acquired nasolacrimal duct obstruction (PANDO) on irrigation/probing and dacryocystography (DCG) or lacrimal scintigraphy; recurrent acute dacryocystitis; canalicular stenosis or obstruction following trauma, chemotherapy, or radiation; and congenital nasolacrimal duct obstruction (CNLDO) unresponsive to conservative probing beyond 12–18 months.

• ORBITAL DISORDERS — Candidates include: orbital blow-out fractures with >50% floor or medial wall disruption, enophthalmos >2mm, or persistent diplopia within 30° of primary gaze (confirmed on CT orbit); thyroid eye disease with compressive optic neuropathy (Dolman/Rootman criteria); orbital tumors (capillary hemangioma, lymphoma, dermoid, rhabdomyosarcoma, optic nerve sheath meningioma) confirmed on orbital MRI; anophthalmic socket requiring volume augmentation or implant exchange.

• PERIOCULAR MALIGNANCY — Patients with histologically confirmed eyelid malignancies (basal cell carcinoma, sebaceous gland carcinoma, squamous cell carcinoma, Merkel cell carcinoma) requiring Mohs micrographic surgery or wide local excision with reconstruction; map biopsy margins confirming clear resection margins before reconstruction is performed.

• REQUIRED DIAGNOSTIC WORKUP:

* Slit-lamp biomicroscopy and dilated fundus examination

* CT orbit (axial/coronal/sagittal, 1mm cuts, bone and soft tissue windows) — mandatory for orbital fractures, tumors, thyroid eye disease

* MRI orbit with fat suppression (STIR sequences) — for soft tissue characterization and nerve compression

* Hertel exophthalmometry baseline

* Levator function measurement, margin reflex distance (MRD1, MRD2), lagophthalmos assessment

* Schirmer's test and tear break-up time (dry eye must be optimized preoperatively)

* Dacryocystography (DCG) or lacrimal scintigraphy for lacrimal obstruction

* Hess chart and orthoptic assessment for diplopia workup

* Thyroid function tests (TSH, Free T4, TRAb), inflammatory markers (CRP, ESR) for thyroid eye disease

* Histopathology / biopsy report for malignant or suspected malignant lesions

* Systemic pre-anesthetic workup: CBC, coagulation profile (INR, APTT), metabolic panel, ECG, chest X-ray

• CONTRAINDICATIONS:

* Active dacryocystitis or periorbital cellulitis (defer surgery until infection controlled with IV antibiotics)

* Uncontrolled thyroid eye disease in active inflammatory phase (CAS ≥4 — systemic immunosuppression or IV methylprednisolone pulse therapy required first)

* Severe dry eye with corneal epithelial breakdown (lagophthalmos-creating procedures must be deferred)

* Uncontrolled bleeding diathesis or anticoagulant therapy not bridged appropriately

* Active systemic malignancy with orbital metastasis requiring oncology clearance before elective reconstruction

* Relative contraindication: prior radiation to the orbit (significantly increases reconstructive complexity and complication risk)

EYELID SURGERY

1. Ptosis Repair — The surgical approach is determined by levator function (LF). For LF ≥5mm: levator aponeurosis advancement/repair (external approach, Fasanella-Servat for mild ptosis) is the gold standard, offering precise intraoperative height adjustment under local anesthesia with the patient sitting up. For LF <4mm: frontalis suspension using autologous fascia lata (Crawford technique — harvested from the thigh, preferred in children) or synthetic materials (Gore-Tex, Mersilene mesh, Prolene) creates a mechanical sling linking the eyelid to the frontalis muscle. Adjustable suture ptosis repair allows postoperative fine-tuning under topical anesthesia within 24 hours of surgery.

2. Blepharoplasty (Upper and Lower) — Upper lid blepharoplasty excises redundant skin and prolapsed orbital fat through a concealed lid crease incision using radiofrequency/CO₂ laser for hemostasis. Lower lid blepharoplasty can be performed via transcutaneous (skin-muscle flap) or transconjunctival approach (scarless, preferred for fat redistribution without significant skin excess). Fat repositioning into the tear trough is the modern aesthetic standard, avoiding the hollow post-blepharoplasty appearance of simple fat excision.

3. Entropion/Ectropion Repair — Involutional ectropion is corrected via horizontal lid shortening (lateral tarsal strip — LTS procedure — the current benchmark), combined with medial canthal tendon tightening or medial spindle procedure as indicated. Cicatricial ectropion requires mucous membrane grafting (hard palate, buccal mucosa, or ear cartilage) to address posterior lamellar shortening. Involutional entropion is corrected by Jones retractor plication and horizontal lid shortening or the Wies procedure (full-thickness transverse lid split with suture rotation), with >95% long-term success.

LACRIMAL SURGERY

4. Dacryocystorhinostomy (DCR) — The definitive treatment for NLDO. Endoscopic (endonasal) DCR using a powered microdebrider, Kerrison rongeur, and KTP or diode laser to create a rhinostomy (bone window between the lacrimal sac and nasal cavity) has replaced external DCR as the preferred approach in most high-volume centers — no external scar, faster recovery, equivalent patency rates (85–92% at 1 year). Bicanalicular intubation with Crawford tubes (silicone stents left for 3–6 months) optimizes lumen patency. External DCR (Lynch incision) remains indicated for revision cases, tumors, or complex anatomy. Adjunctive mitomycin-C (0.02–0.04 mg/mL topical application intraoperatively) is used in revision cases to reduce fibrosis.

5. Canalicular Repair — Canalicular lacerations are repaired over a monocanalicular (Mini-Monoka) or bicanalicular silicone stent under the operating microscope within 24–48 hours of injury for best outcomes.

ORBITAL SURGERY

6. Orbital Fracture Repair — Pure blow-out fractures are repaired via transconjunctival approach (Fornix incision with or without lateral canthotomy) using intraoperative endoscopy for visualization of the posterior shelf. Alloplastic implants — porous polyethylene (Medpor), titanium mesh, or bioresorbable polylactic acid/polyglycolic acid sheets — reconstruct the orbital floor or medial wall. Intraoperative computer-aided surgical navigation (BrainLab, Stryker systems) integrated with pre-operative CT allows real-time implant positioning to sub-millimeter accuracy, dramatically improving enophthalmos correction and diplopia resolution outcomes.

7. Orbital Decompression for Thyroid Eye Disease — Balanced two-wall (medial + lateral or floor + medial) or three-wall decompression using endoscopic and external combined approaches, with intraoperative neuronavigation, reliably reduces proptosis by 4–8mm while minimizing the risk of new-onset diplopia. Fat decompression (removal of orbital adipose tissue alone) is an emerging technique for mild-to-moderate proptosis with low strabismus risk.

8. Orbital Tumor Excision / Enucleation / Evisceration / Exenteration — Orbital tumors are approached via anterior orbitotomy, lateral orbitotomy (Kronlein approach), superior or medial orbitotomy, or endoscopic orbital surgery depending on location. Enucleation (globe removal) uses a porous orbital implant (Medpor, hydroxyapatite) integrated with the extraocular muscles for prosthesis motility. Evisceration (preservation of scleral shell) is used for blind painful eyes. Orbital exenteration for advanced malignancy is combined with reconstructive flap surgery (temporoparietal fascia flap, split-thickness skin graft, or free flap microvascular reconstruction).

PERIOCULAR MALIGNANCY

9. Eyelid Tumor Excision and Reconstruction — Margin-controlled excision (Mohs micrographic surgery or frozen section control) is followed by reconstruction tailored to defect size and location: small defects (≤25% lid) by direct closure; medium defects by Hughes tarsoconjunctival flap (lower lid) or Cutler-Beard bridge flap (upper lid); large defects by free tarsoconjunctival grafts, mucous membrane grafts, and myocutaneous flaps. Sentinel lymph node biopsy (SLNB) is performed for sebaceous gland carcinoma and high-risk SCC.

ADVANCED TECHNOLOGIES IN USE AT GAF PARTNER HOSPITALS:

• Endoscopic DCR with powered instrumentation and KTP/diode laser

• Intraoperative surgical navigation (BrainLab, Stryker) for orbital fracture and tumor surgery

• Radiofrequency and CO₂ laser-assisted blepharoplasty

• Intraoperative frozen section histopathology for margin control

• High-resolution intraoperative endoscopy for lacrimal and orbital work

• 3D-printed patient-specific orbital implants for complex reconstructions (available at select centers)

PHASE 1 — PRE-ARRIVAL PLANNING (4–8 weeks before travel)

• GAF Healthcare case manager reviews your medical records, imaging (CT/MRI), biopsy reports, and ophthalmology notes.

• Virtual consultation arranged with the assigned oculoplastic surgeon at the partner hospital.

• Surgical plan, implant selection, and admission dates confirmed.

• e-Medical Visa application supported (India) or UAE entry/visit visa arranged.

• Pre-operative investigations checklist sent; any blood tests or imaging that can be done at home before travel are identified to minimize in-country preparation time.

• Anticoagulants (warfarin, aspirin, clopidogrel) cessation plan provided in coordination with the patient's cardiologist or GP (typically stop 5–7 days pre-op per surgeon guidance).

PHASE 2 — ARRIVAL AND PRE-OPERATIVE WORKUP (Days 1–2)

• GAF Healthcare airport representative meets the patient and attendant; private transfer to hospital or affiliated accommodation.

• Day 1: Admission and baseline investigations — CBC, coagulation profile, metabolic panel, ECG, chest X-ray, blood group and cross-match (if applicable).

• Ophthalmology workup: slit-lamp exam, Hertel exophthalmometry, Schirmer's test, MRD/levator function documentation, Hess chart (if diplopia).

• CT or MRI review by surgical team; surgical plan finalized.

• Pre-anesthetic consultation; anesthesia type confirmed (local with sedation / general anesthesia).

• Nil by mouth (NBM) instructions issued (typically 6 hours solid food, 2 hours clear fluids before GA).

• Informed consent obtained with professional interpreter if needed.

PHASE 3 — SURGERY DAY (Day 2 or 3)

• Operating time: 45 minutes to 4 hours depending on procedure complexity (simple ptosis repair ~45–90 min; orbital fracture repair with navigation ~2–3 hours; combined procedures or exenteration ~3–5 hours).

• Anesthesia: Topical/local + intravenous sedation (MAC anesthesia) for eyelid-only procedures; general anesthesia (GA) for orbital, lacrimal, or combined procedures.

• Intraoperative navigation activated (orbital cases); endoscope inserted (DCR cases).

• Implant/stent/graft positioned; wound closed with absorbable (deep) and non-absorbable (skin) sutures.

• Eye pad or conformer placed; antibiotic ointment applied.

• Recovery room observation: 1–3 hours post-GA; pain, intraocular pressure (IOP), and vital signs monitored.

PHASE 4 — IMMEDIATE POST-OPERATIVE PERIOD (Days 3–5)

• Hospital stay: Day-case discharge for simple eyelid procedures; 1–2 nights admission for lacrimal surgery; 2–3 nights for orbital surgery or complex reconstruction.

• Ice packs applied to periorbital area every 20 minutes for the first 48 hours to minimize edema.

• Topical antibiotic-steroid drops (e.g., Tobramycin-Dexamethasone QID) and lubricating eye drops commenced.

• Oral analgesics (paracetamol ± mild NSAID); prophylactic oral antibiotics for 5–7 days.

• Wound inspection at Day 2–3; first dressing change.

• Non-absorbable skin sutures removed at Day 7–10 (or at the patient's home country by local physician using the discharge summary provided).

PHASE 5 — IN-COUNTRY RECOVERY (Days 5–21)

• Patients stay in GAF-affiliated serviced apartments or hotel near the hospital for surgeon follow-up visits at Day 5–7 and Day 10–14.

• Minor eyelid surgery patients: cleared to fly at Day 7–10 if wound is clean, no active infection, IOP stable, and no corneal complications.

• Lacrimal (DCR) patients: cleared at Day 10–14; silicone stents remain in situ and are removed at 3–6 months by a local ophthalmologist (GAF provides a referral letter and stent removal instructions).

• Orbital fracture repair / complex reconstruction patients: cleared to fly at Day 14–21 pending CT orbit review confirming implant position, resolution of diplopia trajectory, and no orbital hematoma.

• ALL patients: cleared to fly only when the surgeon formally documents fit-to-fly status in the discharge certificate.

PHASE 6 — LONG-TERM RECOVERY MILESTONES

• Week 1–2: Bruising and periorbital edema peak and then progressively subside (90% resolution by 4–6 weeks).

• Week 2–4: Return to light desk work and non-strenuous daily activities.

• Week 6: Most patients resume normal activities; driving re-assessed by surgeon.

• Month 3: Scar maturation in progress; final aesthetic result not fully evident until 3–6 months post-surgery.

• Month 3–6: DCR silicone stent removal by local ophthalmologist.

• Month 6–12: Final surgical outcome assessment; secondary or revision procedures planned if indicated (e.g., minor lid height adjustment, lagophthalmos correction, scar revision).

• Remote follow-up: GAF Healthcare coordinates telemedicine follow-up consultations with the operating surgeon at 1 month, 3 months, and 6 months post-discharge.